InflaRx NV (IFRX)
0.8562
+0.02
(+3.00%)
USD |
NASDAQ |
Feb 13, 16:00
0.838
-0.02
(-2.13%)
After-Hours: 17:32
InflaRx Cash from Investing (Quarterly) : 2.795M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| CDT Equity, Inc. | -0.998M |
| LENZ Therapeutics, Inc. | -4.333M |
| Liminatus Pharma, Inc. | -0.0131M |
| Oruka Therapeutics, Inc. | -122.45M |
| Maze Therapeutics, Inc. | -66.88M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -11.30M |
| Cash from Financing (Quarterly) | 0.8216M |
| Free Cash Flow | -47.11M |
| Free Cash Flow Per Share (Quarterly) | -0.1684 |
| Free Cash Flow to Equity (Quarterly) | -11.84M |
| Free Cash Flow to Firm (Quarterly) | -11.39M |
| Free Cash Flow Yield | -85.41% |